Catalytic application of recyclable silica-supported bismuth(III) chloride in the benzo[N,N]-heterocyclic condensation

Ca(IO3)2 nanoparticles: fabrication and application as an eco-friendly and recyclable catalyst for the green synthesis of quinoxalines, pyridopyrazines, and 2,3-dicyano pyrazines

In this paper, calcium iodate nanoparticles were first synthesized by the modified reaction of Ca(NO₃)₂ and KIO₃ in an aqueous medium under ultrasonic irradiation. The structure of nanocatalyst was then characterized by FT-IR, FESEM, EDX, XRD, and BET techniques. Afterward, the fabricated Ca(IO₃)₂ was applied as a nanocatalyst in the facile synthesis of heterocycles including quinoxalines, 5,6-dicyano pyrazines, and pyrido[2,3-b]pyrazines. For this purpose, the feasibility of the reaction in the presence of different catalyst amounts, solvents, and temperatures was first investigated. Next, the target compounds were obtained by the condensation reaction of aryl-1,2-diamines or 2,3-diaminomaleonitrile with 1,2-diketones in the presence of a catalytic amount of Ca(IO₃)₂ in ethanol or acetic acid solvents at ambient temperature in good to excellent yields. One of the salient advantages of this work is the synthesis of calcium iodate nanoparticles by chemical precipitation method and its application as a heterogeneous nanocatalyst for the first time in the synthesis of organic compounds. The other important benefits of this process are the use of an inexpensive, safe, stable and recyclable catalyst, high product yields, short reaction times, and easy isolation of the product in pure form.

The crystal structure of 7-Bromo-2-(4-chloro-phenyl)-quinoxaline, C14H9BrClN2

C14H8BrClN2, monoclinic, P21/n (no. 14), a = 17.1347(11) Å, b = 3.8441(2) Å, c = 18.4127(12) Å, β = 97.861(2)°, V = 1201.40(13) Å3, Z = 4, R gt (F) = 0.0388, wR ref (F 2) = 0.1302, T = 170 K.

Recent advances in the synthesis and reactivity of quinoxaline

Quinoxalines are observed in several bioactive molecules and have been widely employed in designing molecules for DSSC's, optoelectronics, and sensing applications. Therefore, developing newer synthetic routes as well as novel ways for their functionalization is apparent.

Inonotus obliquus - from folk medicine to clinical use

The Inonotus obliquus (I. obliquus) mushroom was traditionally used to treat various gastrointestinal diseases. For many years, mounting evidence has indicated the potential of I. obliquus extracts for treatment of viral and parasitic infections. Furthermore, substances from I. obiquus have been shown to stimulate the immune system. The most promising finding was the demonstration that I. obliquus has hypoglycemic and insulin sensitivity potential. This review summarizes the therapeutic potential of I. obliquus extracts in counteracting the progression of cancers and diabetes mellitus as well as their antiviral and antiparasitic activities and antioxidant role. As shown by literature data, various authors have tried to determine the molecular mechanism of action of I. obliquus extracts. Two mechanisms of action of I. obliquus extracts are currently emerging. The first is associated with the broad-sense impact on antioxidant enzymes and the level of reactive oxygen species (ROS). The other is related to peroxisome proliferator-activated receptor gamma (PPARγ) effects. This receptor may be a key factor in the anti-inflammatory, antioxidant, and anti-cancer activity of I. obliquus extracts. It can be concluded that I. obliquus fits the definition of functional food and has a potentially positive effect on health beyond basic nutrition; however, studies that meet the evidence-based medicine (EBM) criteria are needed.

•

Extracts or polysaccharides from I. obliquus exhibit an anti-cancer potential in vitro.

•

Extracts or polysaccharides from I. obliquus exhibit anti-inflammation potential.

•

Extracts or polysaccharides from I. obliquus exhibit hypoglycemic and insulin sensitivity potential.

An “all-water” strategy for regiocontrolled synthesis of 2-aryl quinoxalines

CascadeN-aroylmethylation–reduction–condensation process as novel strategy of “all water chemistry” for first generalized regioselective synthesis of 2-aryl quinoxalines.